Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-01 4:50 pm Sale | 2022-03-31 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 44,441,416 80.100% | -12,904,378 (-22.50%) | Filing History |
| 2022-03-15 09:00 am Unchanged | 2022-03-15 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing History |
| 2022-02-18 8:47 pm Purchase | 2022-02-17 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 20,982,190 (+57.70%) | Filing History |
| 2022-02-11 3:15 pm Sale | 2022-02-09 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 36,363,604 76.700% | -20,982,190 (-36.59%) | Filing History |
| 2022-02-11 2:10 pm Sale | 2021-12-31 | 13G | INNOVIVA INC INVA | Renaissance Technologies LLC | 5,295,133 7.620% | -2,196,209 (-29.32%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 6,800,195 9.790% | 204,712 (+3.10%) | Filing History |
| 2022-02-01 6:34 pm Purchase | 2022-02-01 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 26,404,378 (+85.34%) | Filing History |
| 2022-02-01 1:48 pm Purchase | 2021-12-31 | 13G | INNOVIVA INC INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,683,485 5.300% | 3,683,485 (New Position) | Filing History |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 9,008,758 13.000% | -2,151,788 (-19.28%) | Filing History |
| 2021-11-01 09:27 am Sale | 2021-10-28 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 30,941,416 73.800% | -26,404,378 (-46.04%) | Filing History |
| 2021-06-11 5:37 pm Purchase | 2021-06-11 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 75.500% | 12,537,950 (+27.98%) | Filing History |
| 2021-06-07 4:43 pm Sale | 2021-05-31 | 13G | INNOVIVA INC INVA | Renaissance Technologies LLC | 7,491,342 10.790% | -390,460 (-4.95%) | Filing History |
| 2021-05-25 5:05 pm Unchanged | 2021-05-25 | 13D | INNOVIVA INC INVA | Sarissa Capital Management LP | 6,414,000 9.240% | 0 (Unchanged) | Filing History |
| 2021-05-25 4:24 pm Sale | 2021-05-20 | 13D | INNOVIVA INC INVA | GSK plc | 0 0.000% | -32,005,260 (Position Closed) | Filing History |